Sprycel and Sucralfate drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Sprycel (dasatinib) and Sucralfate (sucralfate). Common drug interactions include oedema among females and constipation among males.

The phase IV clinical study analyzes what interactions people have when they take Sprycel and Sucralfate. It is created by eHealthMe based on reports of 55 people who take the same drugs from the FDA, and is updated regularly.

What is Sprycel?

Sprycel has active ingredients of dasatinib. It is often used in chronic myelogenous leukemia (cml). eHealthMe is studying from 29,788 Sprycel users. Check the latest studies of Sprycel.

What is Sucralfate?

Sucralfate has active ingredients of sucralfate. It is often used in gastroesophageal reflux disease. eHealthMe is studying from 17,548 Sucralfate users. Check the latest studies of Sucralfate.

On Jul, 31, 2026

55 people who take Sprycel and Sucralfate together, and have interactions are studied.

Sprycel and Sucralfate drug interactions.

What are the common drug interactions of Sprycel and Sucralfate, by gender? *:

female:

Oedema (fluid collection in tissue)
Pain
Pneumonitis (inflammation of the walls of the alveoli in the lungs)
Respiratory failure (inadequate gas exchange by the respiratory system)
Skin disorder (skin disease)
Stomatitis (inflammation of mucous membrane of mouth)
Tendon disorder (disease of tendon)
Uveitis (inflammation of the uvea)
Vasomotor rhinitis (stuffy nose)
Pulmonary oedema (fluid accumulation in the lungs)

male:

Constipation
Sinusitis (inflammation of sinus)
Nasopharyngitis (inflammation of the nasopharynx)
Neuropathy peripheral (surface nerve damage)
Pain in extremity
Paraesthesia (sensation of tingling, tickling, prickling, pricking, or burning of a person's skin with no apparent long-term physical effect)
Photophobia (extreme sensitivity to light)
Platelet count decreased
Pleural effusion (water on the lungs)
Staphylococcal infection (an infection with staphylococcus bacteria)

What are the common drug interactions of Sprycel and Sucralfate, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

Bone pain
Myalgia (muscle pain)
Arthralgia (joint pain)
Bone density decreased
Fatigue (feeling of tiredness)
Headache (pain in head)
Rhabdomyolysis (a condition in which damaged skeletal muscle tissue breaks down)

40-49:

Arthralgia (joint pain)
Deafness
Dyspepsia (indigestion)
Erythema nodosum (skin inflammation that results in reddish, painful, tender lumps most commonly located in the front of the legs below)
Fatigue (feeling of tiredness)
Fluid retention (an abnormal accumulation of fluid in the blood)
Fungal infection
Genital pain (pain in genital)
Headache (pain in head)
Intraocular pressure increased

50-59:

Bronchitis (inflammation of the mucous membrane in the bronchial tubes)
Generalised oedema (swelling all over the body)
Pleural effusion (water on the lungs)
Pulmonary oedema (fluid accumulation in the lungs)
Rash
Circulatory collapse
Shock (a life-threatening condition with symptoms like low blood pressure, weakness, shallow breathing, cold, clammy skin)
Abdominal pain upper
Asthma
Blood pressure decreased

60+:

Acute respiratory distress syndrome
Fibrin d dimer increased
Rash
Malignant neoplasm progression (cancer tumour came back)
Platelet count decreased
Pulmonary oedema (fluid accumulation in the lungs)
Drug ineffective
Hypoglycaemia (deficiency of glucose in the bloodstream)
Abdominal pain
Alopecia (absence of hair from areas of the body)

What are the existing conditions these people have? *

Chronic Myeloid Leukaemia (long lasting type of cancer that starts in the blood-forming cells of the bone marrow and invades the blood): 35 people, 63.64%
Leukaemia (blood or bone marrow cancer): 4 people, 7.27%
Marrow Hyperplasia (increased bone marrow): 3 people, 5.45%

* Approximation only. Some reports may have incomplete information.

Do you take Sprycel and Sucralfate?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously